Kuppe et al. Allergy, Asthma & Clinical Immunology 2012, 8:6 http://www.aacijournal.com/content/8/1/6 systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996, 128:275–278. 2. Jordan MB, Hildeman D, Kappler J, Marrack P: An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004, 104:735–743. 3. Ravelli A: Macrophage activation syndrome. Current Opinion in Rheumatology 2002, 14:548–552. 4. Stepp SE: Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis. Science 1999, 286:1957–1959. 5. Weitzman S: Approach to hemophagocytic syndromes hematology / the education program of the American society of hematology. American society of hematology. Education Program 2011, 2011:178–183. 6. Cerfolio RJ, et al: Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999, 67:933–936. 7. Anthony PP: Inflammatory pseudotumour (plasma cell granuloma) of lung, liver and other organs. Histopathology 1993, 23:501–503. 8. Melloni G, et al: Inflammatory pseudotumor of the lung in adults. Ann Thorac Surg 2005, 79:426–432. 9. Rohrlich P, Peuchmaur M, de Napoli Cocci S, Gasselin ID, Garel C, Aigrain Y, Galanaud P, Vilmer E, Emilie D: Interleukin-6 and interleukin-1 beta production in a pediatric plasma cell granuloma of the lung. Am J Surg Pathol 1995, 19:596–603. 10. Doski JJ, et al: Corticosteroids in the management of unresected plasma cell granuloma (inflammatory pseudotumor) of the lung. J Pediatr Surg 1991, 26:1064–1066. 11. Schaer DJ, et al: Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol 2005, 74:6–10. 12. Sumegi J, et al: Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis. Blood 2011, 117:e151–e160. 13. Schneider EM, et al: Autophagy and ATP-induced anti-apoptosis in antigen presenting cells (APC) follows the cytokine storm in patients after major trauma. J Cell Commun Signaling 2011, 5:145–156. 14. Henter J-I, et al: Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002, 100:2367–2373. 15. Miettunen P, Jayanthan A, Narendran A: 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis. Pediatr Rheumatol 2008, 6:S13. 16. Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ: Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 2011, 50:417–419. doi:10.1186/1710-1492-8-6 Cite this article as: Kuppe et al.: Macrophage activation syndrome in a patient with pulmonary inflammatory myofibroblastic tumour. Allergy, Asthma & Clinical Immunology 2012 8:6. Page 6 of 6 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit